A detailed history of Charles Schwab Investment Management Inc transactions in Personalis, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 22,941 shares of PSNL stock, worth $134,893. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,941
Previous 22,941 -0.0%
Holding current value
$134,893
Previous $123,000 7.32%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$1.78 - $3.64 $40,834 - $83,505
22,941 New
22,941 $45,000
Q2 2022

Aug 15, 2022

SELL
$3.27 - $8.76 $347,653 - $931,328
-106,316 Reduced 40.56%
155,830 $538,000
Q1 2022

May 13, 2022

BUY
$7.56 - $14.3 $55,029 - $104,089
7,279 Added 2.86%
262,146 $2.15 Million
Q4 2021

Feb 11, 2022

BUY
$12.24 - $21.25 $62,007 - $107,652
5,066 Added 2.03%
254,867 $3.64 Million
Q3 2021

Nov 16, 2021

BUY
$16.69 - $26.05 $741,503 - $1.16 Million
44,428 Added 21.63%
249,801 $4.81 Million
Q2 2021

Aug 16, 2021

BUY
$18.15 - $27.75 $374,325 - $572,316
20,624 Added 11.16%
205,373 $5.2 Million
Q1 2021

May 17, 2021

BUY
$20.71 - $51.02 $627,823 - $1.55 Million
30,315 Added 19.63%
184,749 $4.55 Million
Q4 2020

Feb 16, 2021

BUY
$21.84 - $44.0 $70,586 - $142,208
3,232 Added 2.14%
154,434 $5.65 Million
Q3 2020

Nov 13, 2020

BUY
$13.63 - $24.12 $935,386 - $1.66 Million
68,627 Added 83.11%
151,202 $3.28 Million
Q2 2020

Aug 14, 2020

BUY
$7.65 - $14.11 $83,905 - $154,758
10,968 Added 15.32%
82,575 $1.07 Million
Q1 2020

May 15, 2020

BUY
$4.75 - $12.41 $104,447 - $272,883
21,989 Added 44.32%
71,607 $578,000
Q4 2019

Feb 07, 2020

BUY
$8.73 - $12.95 $4,766 - $7,070
546 Added 1.11%
49,618 $541,000
Q3 2019

Nov 08, 2019

BUY
$14.16 - $25.34 $694,859 - $1.24 Million
49,072 New
49,072 $721,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $270M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.